Members
Education: M.Sc. Mechanical Engineering, Economics.
Background and other assignments: CEO of CellaVision from 2015 to 2020. 30 years of industry experience in medical technology. Previous experience include CEO of Mölnlycke Healthcare and senior positions at Gambro, Getinge/Arjo and Cooper Companies. Board experience from Etac and Sobi. Since 2026 Chairman of the Board of Malmö FF.
Independent of company and major shareholders.
Education: Cand. Polit., Economics.
Background and other assignments: Chairman of Tandlægen.dk - Holding A/S and Qufora A/S. Ordinary Board member in Sonion A/S, Colony ApS and Technical University of Denmark (DTU) POC Board. Former senior positions at Demant A/S, including President Demant Inc.
Independent of company and major shareholders.
Education: Medical candidate, B.Sc. Medicine, M.Sc. Bioengineering, B.Sc. Mathematics, Ph.D. Neurophysiology, Ph.D. Engineering (hc), Graduate from Swedish armed forces language school.
Background and other assignments: Founder and General partner Fåhraeus Startup and Growth I & II, Chairman of the Board EQL Pharma AB (publ). Board member Ossdsign AB (publ), Bionamic AB, Iconovo AB (publ) and Flatfrog Laboratories AB. Founder of EQL Pharma AB and Flatfrog Laboratories AB among others.
Independent of company and major shareholders.
Education: B.Sc. Business Administration, University Diploma in Journalism.
Background and other assignments: Board member Exsitec Holding AB (publ.) and Broviken Gruppen AB. Former experiences include CFO at Addnode Group, Acando and Protect Data, Board member Metria, and Authorized Public Accountant at PwC.
Independent of company and major shareholders.
Education: Biological Laboratory Science.
Background and other assignments: Senior Healthcare Advisor. Former CEO of The Binding Site Group Ltd (part of Thermo Fisher Scientific). Past experiences include CEO of Hemostasis, Hematology, and Specialty Diagnostics at Siemens Healthineers and Division President of Immuno Diagnostic & Clinical Diagnostic Division at Thermo Fisher Scientific.
Independent of company and major shareholders.
Education: MSc. Industrial Economics and Management, and BSc. Mechanical Engineering.
Background and other assignments: Chief Investment Officer at AB Grenspecialisten. Past experiences include Credit Research at Danske Bank Markets and Nordea Markets. Ordinary Board Member in Exsitex, Trianon, Lime Technologies and Boule Diagnostics.
Independent of company. Dependent on major shareholders.
Education: M.Sc. Engineering Physics.
Employed since 2005. Current position, Engineering Manager.
Board member appointed by the unions since 2020.
Education: High school Mechanical Engineer.
Employed since 2006. Current position: Strategic Sourcing Manager.
Board member appointed by the unions since 2025.
Nomination Committee
The Nomination Committee consists of Nicklas Hansen, appointed by William Demant Invest A/S, Joel Eklund (Chairman of the Nomination Committee), appointed by Grenlunden CEVI AB, Erik Ståhl Hallengren, appointed by SEB Funds and Christer Fåhraeus, appointed by Christer Fåhraeus and companies.
Shareholders wishing to submit proposals to the Nomination Committee can email ir@cellavision.com or ordinary mail to: The Nomination Committee, CellaVision AB, Mobilvägen 12, 223 62 Lund.
Audit & Remuneration Committees
Audit Committee
The Board appointed Ann-Charlotte Jarleryd, Zlatko Rihter and Mikael Worning as members of the Company’s Auditing Committee. Ann-Charlotte Jarleryd shall be the chairman of the committee. The assignment of the committee is outlined in the rules of procedure for the Board.
Remuneration Committee
The Board appointed Zlatko Rihter, Christer Fåhraeus and Stefan Wolf as members of the Company’s Remuneration Committee. Zlatko Rihter shall be the chairman of the committee. The assignment of the committee is outlined in the rules of procedure for the Board.